Trade Summary

2 days ago, Blum Robert I, serving as President & CEO at CYTOKINETICS INC (CYTK), sold 7,500 shares at $77.21 per share, for a total transaction value of $579,075.00. Following this transaction, Blum Robert I now holds 392,830 shares of CYTK.

This sale represents a 1.87% decrease in Blum Robert I's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Wednesday, May 27, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 28, 2026 at 4:21 PM ET, 1 day after the trade was made.

CYTOKINETICS INC operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.